Published in J Hypertens on September 01, 2013
Role of Wrist Based Blood Pressure Monitoring in Clinical Practice | NCT03862742
HIGH Altitude CArdiovascular REsearch Latin America Population Study (HIGHCARE-LAPS) | NCT04751292
Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens (2014) 1.25
Nocturnal blood pressure dipping: systolic, diastolic or both? J Hypertens (2014) 1.13
Racial differences in abnormal ambulatory blood pressure monitoring measures: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Hypertens (2014) 1.04
Validation of the integration of technology that measures additional "vascular" indices into an ambulatory blood pressure monitoring system. Med Devices (Auckl) (2014) 0.97
Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study. Am J Hypertens (2014) 0.97
Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review. Ann Intern Med (2015) 0.97
Prevalence of Masked Hypertension and Its Association With Subclinical Cardiovascular Disease in African Americans: Results From the Jackson Heart Study. J Am Heart Assoc (2016) 0.93
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure. Hypertension (2015) 0.92
The 24-hour pulse wave velocity, aortic augmentation index, and central blood pressure in normotensive volunteers. Vasc Health Risk Manag (2014) 0.91
Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study. Hypertension (2016) 0.89
Impact of Gender on the Association of Epicardial Fat Thickness, Obesity, and Circadian Blood Pressure Pattern in Hypertensive Patients. J Diabetes Res (2015) 0.89
Evaluation of Criteria to Detect Masked Hypertension. J Clin Hypertens (Greenwich) (2016) 0.89
Ambulatory blood pressure monitoring in clinical practice: a review. Am J Med (2014) 0.87
Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension (2014) 0.86
Treatment-induced changes in ambulatory arterial stiffness index: one-year prospective study and meta-analysis of evidence. Hypertens Res (2015) 0.85
Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring. Drugs R D (2014) 0.84
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension. Clin J Am Soc Nephrol (2015) 0.84
I Brazilian position paper on prehypertension, white coat hypertension and masked hypertension: diagnosis and management. Arq Bras Cardiol (2014) 0.84
Renal denervation after Symplicity HTN-3: an update. Curr Hypertens Rep (2014) 0.83
Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010. Vasc Health Risk Manag (2014) 0.83
Rationale and design of the Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension (INSPiRED) trial. Blood Press (2014) 0.83
Intrathecal fentanyl abolishes the exaggerated blood pressure response to cycling in hypertensive men. J Physiol (2016) 0.83
Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results. J Hypertens (2014) 0.83
Impact of cuff positioning on blood pressure measurement accuracy: may a specially designed cuff make a difference? Hypertens Res (2017) 0.83
Tendency for age-specific mortality with hypertension in the European Union from 1980 to 2011. Int J Clin Exp Med (2015) 0.82
Is Isolated Nocturnal Hypertension A Reproducible Phenotype? Am J Hypertens (2015) 0.82
Evaluation of 24-Hour Arterial Stiffness Indices and Central Hemodynamics in Healthy Normotensive Subjects versus Treated or Untreated Hypertensive Patients: A Feasibility Study. Int J Hypertens (2015) 0.82
Renal denervation with standard radiofrequency ablation catheter is effective in 24-hour ambulatory blood pressure reduction - follow-up at 1/3/6/12 months. Neth Heart J (2016) 0.82
Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries. J Am Soc Hypertens (2014) 0.82
Prevalence of hypertension in rural areas of china: a meta-analysis of published studies. PLoS One (2014) 0.82
Masked hypertension and its associated cardiovascular risk in young individuals: the African-PREDICT study. Hypertens Res (2015) 0.81
Are personality traits associated with white-coat and masked hypertension? J Hypertens (2014) 0.81
Short-term blood pressure variability over 24 h and target organ damage in middle-aged men and women. J Hum Hypertens (2015) 0.81
The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010. J Am Soc Hypertens (2014) 0.81
Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center. Clin Exp Gastroenterol (2016) 0.81
Orthostatic hypertension as a predisposing factor for masked hypertension: the J-SHIPP study. Hypertens Res (2016) 0.81
Increasing complexity: which drug class to choose for treatment of hypertension in the elderly? Clin Interv Aging (2014) 0.79
Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hypertens (2015) 0.79
Drug treatment of hypertension in pregnancy. Drugs (2014) 0.79
Ambulatory blood pressure phenotypes and the risk for hypertension. Curr Hypertens Rep (2014) 0.79
White-Coat Effect Among Older Adults: Data From the Jackson Heart Study. J Clin Hypertens (Greenwich) (2015) 0.78
Does sympathetic overactivation feature all hypertensives? Differences of sympathovagal balance according to night/day blood pressure ratio in patients with essential hypertension. Hypertens Res (2016) 0.78
Gestational dietary patterns are not associated with blood pressure changes during pregnancy and early postpartum in a Brazilian prospective cohort. Eur J Nutr (2014) 0.78
Response to: nocturnal blood pressure dipping: systolic, diastolic or both? J Hypertens (2014) 0.78
The Utility of Ambulatory Blood Pressure Monitoring for Diagnosing White Coat Hypertension in Older Adults. Curr Hypertens Rep (2015) 0.78
Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension? Clin Exp Nephrol (2015) 0.78
Intima-Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population-Based Cohort (STANISLAS Cohort Study). J Am Heart Assoc (2016) 0.77
Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness. JMIR Res Protoc (2016) 0.77
Blood pressure changes after high- and low-salt diets: are intermittent arm measures and beat-by-beat finger measures equivalent? J Hum Hypertens (2014) 0.77
Ambulatory blood pressure monitoring is recommended in the clinical management of children with a solitary functioning kidney. Pediatr Nephrol (2014) 0.77
Relationship between serum bilirubin concentration and nondipper hypertension. Int J Clin Exp Med (2014) 0.77
Systemic Hemodynamic Atherothrombotic Syndrome and Resonance Hypothesis of Blood Pressure Variability: Triggering Cardiovascular Events. Korean Circ J (2016) 0.77
White Coat Effect Is Uncommon in Patients With Refractory Hypertension. Hypertension (2017) 0.76
Specific genetic influences on nighttime blood pressure. Am J Hypertens (2014) 0.76
Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension. Front Physiol (2015) 0.76
Ambulatory Blood Pressure Monitoring in Individuals with HIV: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.76
Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study. J Hypertens (2016) 0.76
High daytime and nighttime ambulatory pulse pressure predict poor cognitive function and mild cognitive impairment in hypertensive individuals. J Cereb Blood Flow Metab (2016) 0.75
CoCo trial: Color-coded blood pressure Control, a randomized controlled study. Patient Prefer Adherence (2014) 0.75
24-hour central blood pressure and intermediate cardiovascular phenotypes in untreated subjects. Am J Cardiovasc Dis (2014) 0.75
Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure. Vasc Health Risk Manag (2016) 0.75
Renal vascular calcification and response to renal nerve denervation in resistant hypertension. Medicine (Baltimore) (2017) 0.75
Validation of the TONOPORT VI ambulatory blood pressure monitor in adults according to the European Society of Hypertension International Protocol revision 2010. J Hum Hypertens (2016) 0.75
Time dictates: emerging clinical analyses of the impact of circadian rhythms on diagnosis, prognosis and treatment of disease. Clin Med (2015) 0.75
Relationship of Office and Ambulatory Blood Pressure With Left Ventricular Global Longitudinal Strain. Am J Hypertens (2015) 0.75
Current Practice of Hypertension in India: Focus on Blood Pressure Goals. J Clin Diagn Res (2016) 0.75
Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries. Cardiol Clin (2017) 0.75
Conventional and Ambulatory Blood Pressure as Predictors of Retinal Arteriolar Narrowing. Hypertension (2016) 0.75
Functional capacity and heart rate response: associations with nocturnal hypertension. BMC Cardiovasc Disord (2015) 0.75
Supplement: Cardiology and Therapy. Cardiol Ther (2015) 0.75
The diagnostic value of supine blood pressure in hypertension. Arch Med Sci (2016) 0.75
Ambulatory Blood Pressure Monitoring: Five Decades of More Light and Less Shadows. Arq Bras Cardiol (2016) 0.75
Hypotensive Responses of Reciprocal Supersets versus Traditional Resistance Training in Apparently Healthy Men. Int J Exerc Sci (2017) 0.75
Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure. Nutrients (2016) 0.75
Male prairie voles display cardiovascular dipping associated with an ultradian activity cycle. Physiol Behav (2016) 0.75
Long-term effects of vitamin D supplementation in vitamin D deficient obese children participating in an integrated weight-loss programme (a double-blind placebo-controlled study) - rationale for the study design. BMC Pediatr (2017) 0.75
Relevance to home blood pressure monitoring protocol of blood pressure measurements taken before first- morning micturition and in the afternoon. Arq Bras Cardiol (2014) 0.75
Association among epicardial fat, heart rate recovery and circadian blood pressure variability in patients with hypertension. Clin Hypertens (2015) 0.75
White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens (2017) 0.75
Effect of a cheese rich in angiotensin-converting enzyme-inhibiting peptides (Gamalost(®)) and a Gouda-type cheese on blood pressure: results of a randomised trial. Food Nutr Res (2016) 0.75
Clinical and Epidemiological Implications of 24-Hour Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Kenyan Adults: A Population-Based Study. J Am Heart Assoc (2016) 0.75
Ambulatory blood pressure monitoring phenotypes among individuals with and without diabetes taking antihypertensive medication: the Jackson Heart Study. J Hum Hypertens (2016) 0.75
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients. Hypertens Res (2016) 0.75
Epicardial Fat Thickness and Neutrophil to Lymphocyte Ratio are Increased in Non-Dipper Hypertensive Patients. J Cardiovasc Ultrasound (2016) 0.75
Increased total mortality as a function of 24-h pulse pressure dipping. J Hum Hypertens (2015) 0.75
Exploring diurnal variation using piecewise linear splines: an example using blood pressure. Emerg Themes Epidemiol (2017) 0.75
Neurovascular mechanisms underlying augmented cold-induced reflex cutaneous vasoconstriction in human hypertension. J Physiol (2016) 0.75
STK39 and WNK1 Are Potential Hypertension Susceptibility Genes in the BELHYPGEN Cohort. Medicine (Baltimore) (2016) 0.75
Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene. Sci Rep (2017) 0.75
Cardiovascular Risk Factors and Masked Hypertension: The Jackson Heart Study. Hypertension (2016) 0.75
Associations between cystatin C-based eGFR, ambulatory blood pressure parameters, and in-clinic versus ambulatory blood pressure agreement in older community-living adults. Blood Press Monit (2016) 0.75
Impact of Renal Sympathetic Denervation on Left Ventricular Structure and Function at 1-Year Follow-Up. PLoS One (2016) 0.75
Blood pressure variability and its association with echocardiographic parameters in hypertensive diabetic patients. BMC Cardiovasc Disord (2016) 0.75
Effect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office Blood Pressure. Cardiol Ther (2015) 0.75
The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale. Contemp Clin Trials (2016) 0.75
Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction. Nitric Oxide (2017) 0.75
Masked hypertension-what lies ahead? J Hum Hypertens (2017) 0.75
Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease. Dig Dis Sci (2017) 0.75
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol (2004) 11.63
Point: cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol (1985) (2006) 11.52
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet (2004) 11.13
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med (2011) 11.11
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA (2011) 8.83
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet (2010) 8.39
Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation (2006) 8.18
Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation (2006) 7.01
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet (2009) 6.25
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension (2002) 6.06
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension (2013) 5.88
Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension (2011) 5.73
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res (2009) 5.24
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med (2006) 5.18
Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension (2005) 5.05
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens (2003) 4.91
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res (2014) 4.83
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation (2005) 4.69
Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens (2002) 4.63
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc (2004) 4.48
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Effectiveness of blood pressure control outside the medical setting. Hypertension (2006) 4.38
Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit (2002) 4.02